Next Article in Journal
Factors Predisposing to Non-Tuberculous Mycobacterial Lung Disease in the Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria
Previous Article in Journal
Chronic Obstructive Pulmonary Disease and Sacubitril: Explore the Role of Neprilysin before Its Inhibition
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 86
Issue 5
10.5603/ARM.2018.0042
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease. Response to the Letter of Siniorakis et al.

by
Maciej Liczek
,
Iga Panek
,
Piotr Damiański
,
Olga Jęczeń
,
Jędrzej Jaźwiec
,
Piotr Kuna
and
Michał Panek
*
Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, 90-153 Łódź, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2018, 86(5), 257-259; https://doi.org/10.5603/ARM.2018.0042
Submission received: 14 October 2018 / Revised: 15 October 2018 / Accepted: 15 October 2018 / Published: 30 October 2018

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Neprilysin (NEP) inhibition has become an important issue in cardiology and pulmonology [...]

Share and Cite

MDPI and ACS Style

Liczek, M.; Panek, I.; Damiański, P.; Jęczeń, O.; Jaźwiec, J.; Kuna, P.; Panek, M. Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease. Response to the Letter of Siniorakis et al. Adv. Respir. Med. 2018, 86, 257-259. https://doi.org/10.5603/ARM.2018.0042

AMA Style

Liczek M, Panek I, Damiański P, Jęczeń O, Jaźwiec J, Kuna P, Panek M. Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease. Response to the Letter of Siniorakis et al. Advances in Respiratory Medicine. 2018; 86(5):257-259. https://doi.org/10.5603/ARM.2018.0042

Chicago/Turabian Style

Liczek, Maciej, Iga Panek, Piotr Damiański, Olga Jęczeń, Jędrzej Jaźwiec, Piotr Kuna, and Michał Panek. 2018. "Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease. Response to the Letter of Siniorakis et al." Advances in Respiratory Medicine 86, no. 5: 257-259. https://doi.org/10.5603/ARM.2018.0042

Article Metrics

Back to TopTop